EGFR and hepatocellular carcinoma: What’s more, GOLM1 also acts as a positive regulator of Programmed Cell Death Ligand 1 (PD-L1) expression via the EGFR/Signal Transducer and Activator Of Transcription 3 (STAT3) signaling pathway in the human hepatocellular carcinoma [20].